| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Kodiak Sciences Inc. (KOD) has 8 insiders with recent SEC Form 4 filings, including 47 buys and 13 sells. KOD is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 1.56M | $57.65M | - | |
| CFO | 211.9K | $7.83M | -30,000 | |
| CEO | 175.0K | $6.47M | - | |
| Dir | 40.0K | $1.48M | - | |
| Dir | 40.0K | $1.48M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 2, 2020 | Liang Hong | SVP, Discovery Medicine | Sell | 4,000 | $42.34 | $169,360.00 | -3.0% | |
| Mar 26, 2020 | Liang Hong | SVP, Discovery Medicine | Sell | 4,000 | $47.78 | $191,112.03 | -1.0% | |
| Mar 20, 2020 | Ehrlich Jason84 | See Remarks | Sale+OE | 6,950 | $45.00 | $312,762.30 | -3.8% | |
| Mar 20, 2020 | Levy Richard S | Director | Buy | 1,000 | $44.33 | $44,330.00 | +400.0% | |
| Mar 19, 2020 | Liang Hong | SVP, Discovery Medicine | Sell | 4,000 | $39.45 | $157,810.60 | -1.4% | |
| Mar 18, 2020 | Baker Bros. Advisors LP59 | Director, 10% Owner | Buy | 150,000 | $39.29 | $5,893,804.48 | +0.3% | |
| Feb 26, 2020 | Baker Bros. Advisors LP59 | Director, 10% Owner | Buy | 377,249 | $57.87 | $21,830,241.66 | +0.2% | |
| Dec 6, 2019 | Baker Bros. Advisors LP59 | Director, 10% Owner | Buy | 1,902,173 | $46.00 | $87,499,958.00 | +20.8% | |
| Oct 9, 2018 | Profusek Robert | Director | Buy | 10,000 | $10.00 | $100,000.00 | New | |
| Oct 9, 2018 | Baker Bros. Advisors LP59 | Director, 10% Owner | Buy | 2,500,000 | $10.00 | $25,000,000.00 | +37.6% |